Concentration of UHCL1 in the Serum of Children with Acute Appendicitis, Before and After Surgery, and Its Correlation with CRP and Prealbumin

REFERENCES

• Brackeva B, De Punt V, Kramer G, Costa O, Verhaeghen K, Stangé G, Sadones J, Xavier C, Aerts JM, Gorus FK, Martens GA. Potential of UCHL1 as biomarker for destruction of pancreatic beta cells. J Proteomics. 2015;117:156–167. doi: 10.1016/j.jprot.2015.01.009.
   PubMed Web of Science ®Google Scholar
• Wilson CL, Murphy LB, Leslie J, Kendrick S, French J, Fox CR, Sheerin NS, Fisher A, Robinson JH, Tiniakos DG, Gray DA, Oakley F, Mann DA. Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease. J Hepatol. 2015;63(6):1421–1428. doi: 10.1016/j.jhep.2015.07.034.
   PubMed Web of Science ®Google Scholar
• Hussain S, Bedekovics T, Chesi M, Bergsagel PL, Galardy PJ. UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression. Oncotarget. 2015;6(38):40704–40718. doi: 10.18632/oncotarget.5727.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhang W, Xu J, Wang H, Zhang Z, Chu C, Liu X, Zou Q. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer. Int J Clin Exp Pathol. 2015;8(10):12500–12508.
   PubMed Web of Science ®Google Scholar
• Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, et al. Epigenetic identification of Ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular car-cinoma and other digestive tumors. Hepatology. 2008;48(2):508–518.
   PubMed Web of Science ®Google Scholar
• Hussain S, Foreman O, Perkins SL, Witzig TE, Miles RR, Van Deursen J, et al. The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLP P1 and Akt signaling. Leukemia. 2010;24(9):1641–55.
   PubMed Web of Science ®Google Scholar
• Jang MJ, Baek SH, Kim JH. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Cancer Lett. 2011;302(2):128–135.
   PubMed Web of Science ®Google Scholar
• Zhong J, Zhao M, Ma Y, Luo Q, Liu J, Wang J, et al. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity. Int J Mol Med. 2012;30(2):430–436.
   PubMed Web of Science ®Google Scholar
• Wulfanger J, Biehl K, Tetzner A, Wild P, Ikenberg K, Meyer S, et al. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma. Int J Cancer. 2013;133(11):2522–2532.
   PubMed Web of Science ®Google Scholar
• Zheng S, Qiao G, Min D, Zhang Z, Lin F, Yang Q, et al. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma. Cancer Lett. 2015;359(1):36–46.
   PubMed Web of Science ®Google Scholar
• Gu YY, Yang M, Zhao M, Luo Q, Yang L, Peng H, et al. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways. Tumour Biol. 2015;36:8379–8387. doi: 10.1007/s13277-015-3566-0.
   PubMed Web of Science ®Google Scholar
• DU P, Yao YW, Shi Y, Gu Z, Wang J, Sun ZG, Zuo JK. Uchl1 and its associated proteins were involved in spermatocyte apoptosis in mouse experimental cryptorchidism. Sheng Li Xue Bao. 2014;66(5):528–536.
   PubMedGoogle Scholar
• Kwon J, Mochida K, Wang YL, Sekiguchi S, Sankai T, Aoki S, Ogura A, Yoshikawa Y, Wada K. Ubiquitin C-terminal hydrolase L-1 is essential for the early apoptotic wave of germinal cells and for sperm quality control during spermatogenesis. Biol Reprod. 2005;73(1):29–35.
   PubMed Web of Science ®Google Scholar
• Kwon J, Wang YL, Setsuie R, Sekiguchi S, Sato Y, Sakurai M, Noda M, Aoki S, Yoshikawa Y, Wada K. Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis. Am J Pathol. 2004;165(4):1367–1374.
   PubMed Web of Science ®Google Scholar
• Sankiewicz A, Laudański P, Romanowicz L, Hermanowicz A, Roszkowska-Jakimiec W, Debek W, et al. Development of surface plasmon resonance imaging biosensors for detection of ubiquitin carboxyl-terminal hydrolase L1. Anal Biochem. 2015;469:4–11.
   PubMed Web of Science ®Google Scholar
• Gorodkiewicz E. Surface plasmon resonance imaging sensor for cathepsin determination based in immobilized cystatin. Protein Pept Lett. 2009;16:1379–1385.
   PubMed Web of Science ®Google Scholar
• Gorodkiewicz E, Sieńczyk M, Regulska E, Grzywa R, Pietrusewicz E, Lesner A, et al. Surface plasmon resonance imaging biosensor for cathepsin G besed on a potent inhibitor: Development and applications. Anal Bochem. 2012;423:218–223.
   PubMed Web of Science ®Google Scholar
• Johnsson B, Lofas S, Lindquist G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem. 1991;198:268–277.
   PubMed Web of Science ®Google Scholar
• Gorodkiewicz E, Sankiewicz A, Laudański P. Surface plasmon resonance imaging biosensors for aromatase based on a potent inhibitor and a specific antibody: Sensor development and application for biological material. Cent Eur J Chem. 2014;12:557–567.
   Google Scholar
• Diaz-Arrastia R1, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31(1):19–25. doi: 10.1089/neu.2013.3040.
   PubMed Web of Science ®Google Scholar
• Goto Y, Zeng L, Yeom CJ, Zhu Y, Morinibu A, Shinomiya K, et al. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. 2015;6:6153.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, et al. PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res. 2002;8:192–195.
   PubMed Web of Science ®Google Scholar
• Takami Y, Nakagami H, Morishita R, Katsuya T, Cui TX, Ichikawa T, et al. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation. Arterioscler Thromb Vasc Biol. 2007;27(10):2184–2190.
   PubMed Web of Science ®Google Scholar
• Read NC, Gutsol A, Holterman CE, Carter A, Coulombe J, Gray DA, et al. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis. Biochim Biophys Acta 2014;1842:1028–1040.
   PubMed Web of Science ®Google Scholar
• Hurst-Kennedy J, Chin LS, Li L. Ubiquitin C-terminal hydrolase l1 in tumorigenesis. Biochem Res Int. 2012;2012:123706.
   PubMedGoogle Scholar
• Zhang H, Mao X, Sun Y, Hu R, Luo W, Zhao Z, et al. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis. Mol Med Rep. 2015;12(2):2893–901. doi: 10.3892/mmr.2015.3780.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang M, Zhou W, Ly PT, Cai F, Song W. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression. J Neurochem. 2011;116(6):1160–1170. doi: 10.1111/j.1471-4159.2011.07172.x.
   PubMed Web of Science ®Google Scholar
• Davis CJ1, Sowa D, Keim KS, Kinnare K, Peterson S. The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center.
   Google Scholar